ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) recently declared that the U.S. Food and Drug Administration have granted Breakthrough Therapy designation to NUPLAZID for the treatment of Parkinson's disease psychosis.
Cubist Pharmaceuticals Inc (NASDAQ:CBST) said its president and chief operating officer Robert J. Perez will take over as Chief Executive Officer, effective January 1, 2015, replacing Michael Bonney who is retiring.
Cubist Pharmaceuticals, Inc. (CBST: Quote) Monday said it appointed Chief Operating Officer and President Robert Perez as its CEO, with effect from January 1, 2015, to replace Michael Bonney who will be retiring by the year end.
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) EVP Steven C. Gilman sold 48,125 shares of the company's stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $65.39, for a total ...